Axoft Raises $55 Million Series A to Advance Global Clinical Trials for Soft Brain-Computer Interfaces

Mintz has advised Axoft. Axoft, a neurotechnology company specializing in soft, implantable brain-computer interfaces (iBCIs), has secured $55 million in Series A funding. This investment is…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here